Evaluate the Tolerability and Therapeutic Effects of Repeated Doses of Autologous T Cells With VRX496 in HIV
Clinical trial NCT00295477 · COMPLETED
Trial details
- NCT number
- NCT00295477
- Sponsor
- University of Pennsylvania
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2010-04-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.